<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5.1//EN" "ep-patent-document-v1-5-1.dtd">
<!-- This XML data has been generated under the supervision of the European Patent Office -->
<ep-patent-document id="EP13815988B8W1" file="EP13815988W1B8.xml" lang="en" country="EP" doc-number="2872145" kind="B8" correction-code="W1" date-publ="20220413" status="c" dtd-version="ep-patent-document-v1-5-1">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>BDM Ver 2.0.15 (20th of December) -  2999001/0</B007EP></eptags></B000><B100><B110>2872145</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20220413</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>13815988.4</B210><B220><date>20130712</date></B220><B240><B241><date>20150205</date></B241><B242><date>20170419</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>201261671044 P</B310><B320><date>20120712</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20220413</date><bnum>202215</bnum></B405><B430><date>20150520</date><bnum>201521</bnum></B430><B450><date>20220309</date><bnum>202210</bnum></B450><B452EP><date>20210920</date></B452EP><B480><date>20220413</date><bnum>202215</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  31/55        20060101AFI20151028BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61P  25/14        20060101ALI20151028BHEP        </text></classification-ipcr></B510EP><B520EP><classifications-cpc><classification-cpc sequence="1"><text>A61K  31/55        20130101 FI20140206BHEP        </text></classification-cpc><classification-cpc sequence="2"><text>A61P  25/00        20180101 LI20200320BHEP        </text></classification-cpc><classification-cpc sequence="3"><text>A61P  25/14        20180101 LI20200323BHEP        </text></classification-cpc><classification-cpc sequence="4"><text>A61P  25/22        20180101 LI20200323BHEP        </text></classification-cpc><classification-cpc sequence="5"><text>A61P  25/24        20180101 LI20200324BHEP        </text></classification-cpc><classification-cpc sequence="6"><text>A61P  31/04        20180101 LI20200327BHEP        </text></classification-cpc><classification-cpc sequence="7"><text>A61P  37/02        20180101 LI20200331BHEP        </text></classification-cpc><classification-cpc sequence="8"><text>A61P  43/00        20180101 LI20200331BHEP        </text></classification-cpc></classifications-cpc></B520EP><B540><B541>de</B541><B542>KONDENSIERTE BENZAZEPINE ZUR BEHANDLUNG DES TOURETTE-SYNDROMS</B542><B541>en</B541><B542>FUSED BENZAZEPINES FOR TREATMENT OF TOURETTE'S SYNDROME</B542><B541>fr</B541><B542>BENZAZÉPINES CONDENSÉES POUR LE TRAITEMENT DU SYNDROME DE LA TOURETTE</B542></B540><B560><B561><text>WO-A1-96/13257</text></B561><B561><text>WO-A1-2011/057199</text></B561><B561><text>WO-A1-2012/033874</text></B561><B562><text>ANDREW C MCCREARY ET AL: "The thyrotrophin-releasing hormone analogue MK771 induces tic-like behaviours: the effects of dopamine D1 and D2 receptor antagonists", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 369, no. 1, 1 March 1999 (1999-03-01) , pages 1-9, XP055221494, NL ISSN: 0014-2999, DOI: 10.1016/S0014-2999(99)00039-4</text></B562><B562><text>DURSUN S M ET AL: "SIMILARITIES IN THE PHARMACOLOGY OF SPONTANEOUS AND DOI-INDUCED HEAD-SHAKES SUGGEST 5HT2A RECEPTORS ARE ACTIVE UNDER PHYSIOLOGICAL CONDITIONS", PSYCHOPHARMACOLOGY, SPRINGER VERLAG, BERLIN, DE, vol. 128, no. 2, 1 January 1996 (1996-01-01), pages 198-205, XP001059606, ISSN: 0033-3158, DOI: 10.1007/S002130050125</text></B562><B562><text>QIANG L ET AL: "Discovery of new SCH 39166 analogs as potent and selective dopamine D1 receptor antagonists", BIOORGANIC &amp; MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 20, no. 3, 1 February 2010 (2010-02-01), pages 836-840, XP026861816, ISSN: 0960-894X [retrieved on 2010-01-04]</text></B562><B562><text>ROGER KURLAN, M.D.: 'Tourette's Syndrome.' THE NEW ENGLAND JOURNAL OF MEDICINE vol. 363, 2010, pages 2332 - 2338, XP008176095 Retrieved from the Internet: &lt;URL:http:JJwww.nejm.org/doi/full/ 10.1056lnejmcp 1007805&gt;</text></B562><B562><text>DATABASE PUBMED [Online] 25 October 2006 XP055184772 Retrieved from NCBI Database accession no. 10591286 &amp; ROMACH MK ET AL.: 'Attenuation of the euphoric effects of cocaine by the dopamine DI/D5 antagonist ecopipam (SCH 39166).' ARCH GEN PSYCHIATRY vol. 56, no. 12, 1999, pages 1101 - 1106</text></B562><B562><text>Lynn Dunlap: "TSA, Psyadon to collaborate on drug trial", , May 2011 (2011-05), Retrieved from the Internet: URL:https://missouritsa.org/2011/05/12/tsa -psyadon-to-collaborate-on-drug-trial/ [retrieved on 2017-04-11]</text></B562><B562><text>Jang-Woo Shin ET AL: "Interpretation of Animal Dose and Human Equivalent Dose for Drug Development", The Journal of Korean Oriental Medicine, 1 May 2010 (2010-05-01), pages 1-7, XP55315075, Retrieved from the Internet: URL:http://jkom.org/upload/31-3 01 [01-07].pdf [retrieved on 2016-10-31]</text></B562><B562><text>REAGAN-SHAW SHANNON ET AL: "Dose translation from animal to human studies revisited.", FASEB JOURNAL : OFFICIAL PUBLICATION OF THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY MAR 2008, vol. 22, no. 3, March 2008 (2008-03), pages 659-661, ISSN: 1530-6860</text></B562><B562><text>Anonymous: "Clinica Trials Archive - History of Changes for Study: NCT01244633", , 8 May 2012 (2012-05-08), XP55738348, Retrieved from the Internet: URL:https://www.clinicaltrials.gov/ct2/his tory/NCT01244633?V_5=View#StudyPageTop [retrieved on 2020-10-09]</text></B562><B562><text>ARNE ASTRUP ET AL: "'Randomized Controlled Trials of the D1/D5 Antagonist Ecopipam for Weight Loss in Obese Subjects", OBESITY RESEARCH, BATON ROUGE, LA, US, vol. 15, no. 7, 7 July 2007 (2007-07-07), pages 1717-1731, XP008156118, ISSN: 1071-7323, DOI: 10.1002/HBM.22021</text></B562><B565EP><date>20151103</date></B565EP></B560></B500><B600><B620EP><parent><cdoc><dnum><anum>21170063.8</anum><pnum>3919060</pnum></dnum><date>20210423</date></cdoc></parent></B620EP></B600><B700><B720><B721><snm>CHIPKIN, Richard, E.</snm><adr><str>5266 Pooks Hill Road</str><city>Bethesda, MD 20814</city><ctry>US</ctry></adr></B721><B721><snm>KWAN, Rudolf</snm><adr><str>9 Friar Tuck Circle</str><city>Summit, NJ 07901</city><ctry>US</ctry></adr></B721></B720><B730><B731><snm>Emalex Biosciences, Inc.</snm><iid>101938259</iid><irf>3432P134EPWO-MF</irf><adr><str>330 North Wabash Avenue, Suite 3500</str><city>Chicago, IL 60611</city><ctry>US</ctry></adr></B731></B730><B740><B741><snm>Witte, Weller &amp; Partner Patentanwälte mbB</snm><iid>101020585</iid><adr><str>Postfach 10 54 62</str><city>70047 Stuttgart</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>AL</ctry><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>RS</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>US2013050337</anum></dnum><date>20130712</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2014012034</pnum></dnum><date>20140116</date><bnum>201403</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
